Canaan Partners XI’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5M | Sell |
3,608,109
-536,481
| -13% | -$5.13M | 20.1% | 2 |
|
|
2025
Q1 | $38.5M | Sell |
4,144,590
-35,267
| -0.8% | -$328K | 58.09% | 1 |
|
|
2024
Q4 | $58.1M | Sell |
4,179,857
-230,134
| -5% | -$3.2M | 75.17% | 1 |
|
|
2024
Q3 | $104M | Hold |
4,409,991
| – | – | 87.81% | 1 |
|
|
2024
Q2 | $70.5M | Hold |
4,409,991
| – | – | 85.38% | 1 |
|
|
2024
Q1 | $72.3M | Hold |
4,409,991
| – | – | 79.77% | 1 |
|
|
2023
Q4 | $61.1M | Hold |
4,409,991
| – | – | 76.34% | 1 |
|
|
2023
Q3 | $60.7M | Hold |
4,409,991
| – | – | 53.26% | 1 |
|
|
2023
Q2 | $75.1M | Hold |
4,409,991
| – | – | 53.19% | 1 |
|
|
2023
Q1 | $70.9M | Hold |
4,409,991
| – | – | 50.98% | 1 |
|
|
2022
Q4 | $33.5M | Hold |
4,409,991
| – | – | 26.32% | 2 |
|
|
2022
Q3 | $38.8M | Hold |
4,409,991
| – | – | 15.63% | 2 |
|
|
2022
Q2 | $31.5M | Hold |
4,409,991
| – | – | 11.23% | 3 |
|
|
2022
Q1 | $47.2M | Hold |
4,409,991
| – | – | 19.65% | 3 |
|
|
2021
Q4 | $62M | Buy |
+4,409,991
| New | +$62M | 15.98% | 3 |
|